We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $14.6B
1-Year Est. Return 40.95%
This Fund
S&P 500
This Quarter Est. Return
-1.84%
1 Year Est. Return
+40.95%
3 Year Est. Return
+104.32%
5 Year Est. Return
+50.55%
10 Year Est. Return
+495.11%
AUM
$11.1B
AUM Growth
-$46.6M
Cap. Flow
-$33.5M
Cap. Flow %
-0.3%
Top 10 Hldgs %
37.11%
Holding
2,111
New
475
Increased
396
Reduced
401
Closed
540

Sector Composition

Rank Sector Weight
1 Healthcare 5.32%
2 Technology 4.25%
3 Industrials 3.62%
4 Consumer Discretionary 2.28%
5 Energy 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IR icon
551
Ingersoll Rand
IR
$33.1B
$2.12M 0.02%
33,200
+13,100
+65% +$872K
GRAB icon
552
CALL
Grab
GRAB
$13.7B
$2.11M 0.02%
+596,000
New +$2.13M
ELV icon
553
Elevance Health
ELV
$81.5B
$2.1M 0.02%
4,834
+4,006
+484% +$1.82M
DVN icon
554
Devon Energy
DVN
$51.3B
$2.1M 0.02%
43,965
+10,605
+32% +$534K
MRSH
555
Marsh
MRSH
$94.3B
$2.09M 0.02%
11,000
-5,415
-33% -$1.04M
WFC icon
556
Wells Fargo
WFC
$254B
$2.09M 0.02%
51,141
+40,481
+380% +$1.75M
SRPT icon
557
PUT
Sarepta Therapeutics
SRPT
$1.64B
$2.08M 0.02%
17,200
TJX icon
558
TJX Companies
TJX
$179B
$2.08M 0.02%
23,380
-92,020
-80% -$8.1M
MUB icon
559
iShares National Muni Bond ETF
MUB
$45.2B
$2.08M 0.02%
20,248
+61
+0.3% +$6.43K
DNMR
560
CALL
DELISTED
Danimer Scientific, Inc.
DNMR
$2.07M 0.02%
25,000
-12,500
-33% -$1.13M
BILI icon
561
PUT
Bilibili
BILI
$7.75B
$2.07M 0.02%
150,000
ILMN icon
562
Illumina
ILMN
$29.5B
$2.06M 0.02%
15,393
+7,889
+105% +$1.3M
MRNS
563
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2.05M 0.02%
254,734
+713
+0.3% +$5.93K
APO icon
564
Apollo Global Management
APO
$69B
$2.05M 0.02%
+22,805
New +$1.92M
XRAY icon
565
Dentsply Sirona
XRAY
$2.84B
$2.05M 0.02%
+59,868
New +$2.28M
IRWD icon
566
Ironwood Pharmaceuticals
IRWD
$586M
$2.03M 0.02%
210,740
-120,959
-36% -$1.19M
ANET icon
567
Arista Networks
ANET
$199B
$2M 0.02%
43,600
+11,360
+35% +$506K
IR icon
568
CALL
Ingersoll Rand
IR
$33.1B
$1.98M 0.02%
31,000
BMRN icon
569
CALL
BioMarin Pharmaceuticals
BMRN
$11.9B
$1.97M 0.02%
22,300
+12,300
+123% +$1.09M
VEA icon
570
Vanguard FTSE Developed Markets ETF
VEA
$223B
$1.97M 0.02%
45,072
+27,130
+151% +$1.24M
XLB icon
571
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.72B
$1.96M 0.02%
+50,000
New +$2.05M
ARKG icon
572
ARK Genomic Revolution ETF
ARKG
$1.53B
$1.96M 0.02%
+70,308
New +$2.3M
TXN icon
573
CALL
Texas Instruments
TXN
$248B
$1.94M 0.02%
12,200
-41,800
-77% -$7.13M
AVT icon
574
Avnet
AVT
$6.86B
$1.93M 0.02%
40,000
+29,000
+264% +$1.4M
SWN
575
DELISTED
Southwestern Energy Company
SWN
$1.92M 0.02%
+298,263
New +$1.9M

Similar funds

Jefferies Financial Group's Q3 2023 Portfolio in Review

As of Q3 2023, Jefferies Financial Group held 2,111 positions worth $11.1B, down 0.42% from $11.2B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jefferies Financial Group's Q3 2023 filing shows 475 new, 396 increased, 401 reduced and 540 closed positions. Its largest new stake was Axsome Therapeutics: 553,195 shares worth $38.7M. The largest sale was Allstate, an estimated $281M.

By sector, the portfolio is most concentrated in Healthcare at 5.3% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.

  • Jefferies Financial Group's largest Q3 2023 buy was Axsome Therapeutics: 553,195 shares worth $38.7M.
  • Jefferies Financial Group added most to Invesco QQQ Trust in Q3 2023, an estimated $105M increase.
  • Jefferies Financial Group's biggest Q3 2023 reduction was Allstate, cutting an estimated $281M.
  • Jefferies Financial Group fully exited State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q3 2023, selling an estimated $47.3M.
  • Jefferies Financial Group's ten largest holdings make up 37% of its $11.1B portfolio in Q3 2023.
  • Jefferies Financial Group opened 475 new positions and closed 540 in Q3 2023.
  • Jefferies Financial Group's portfolio value fell 0.42% quarter-over-quarter to $11.1B.

Based on Jefferies Financial Group's 13F filing for Q3 2023, filed 14 Nov 2023.